Page last updated: 2024-11-04

tegafur and Diabetes Mellitus, Type 1

tegafur has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

ExcerptRelevanceReference
"Accordingly, we diagnosed fulminant type 1 diabetes."2.52The development of fulminant type 1 diabetes during chemotherapy for rectal cancer. ( Adachi, J; Gotyo, N; Mimura, M; Watanabe, T, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, J1
Mimura, M1
Gotyo, N1
Watanabe, T1

Reviews

1 review available for tegafur and Diabetes Mellitus, Type 1

ArticleYear
The development of fulminant type 1 diabetes during chemotherapy for rectal cancer.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Diabetes Mellitus, Type 1; Diabetic Ketoacido

2015